Y. Duan

Prognostic Role of S100A8 in Human Solid Cancers: A Systematic Review and Validation

Yanping Wang, W. Fan, Qingyuan Cheng, 2020, Frontiers in Oncology.

Development of novel 9-O-substituted-13-octylberberine derivatives as potential anti-hepatocellular carcinoma agents

Jinyi Xu, Nianguang Li, Xiaoxuan Yu, 2022, Journal of enzyme inhibition and medicinal chemistry.

Design and synthesis of NAD(P)H: Quinone oxidoreductase (NQO1)-activated prodrugs of 23-hydroxybetulinic acid with enhanced antitumor properties.

W. Ye, Shengtao Xu, Jinyi Xu, 2022, European journal of medicinal chemistry.

Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor Effects.

Dong-Hua Yang, Chenbang He, Zhe S Chen, 2022, Journal of medicinal chemistry.

Design, synthesis and biological evaluation of novel 9-N-substituted-13-alkylberberine derivatives from Chinese medicine as anti-hepatocellular carcinoma agents.

C. Gu, Jinyi Xu, Zheying Zhu, 2023, Bioorganic & medicinal chemistry.

Effective suppression of triple negative breast cancer by paclitaxel nanoparticles conjugated with transmembrane TNF-α monoclonal antibody.

W. Fan, Qingyuan Cheng, Mingxia Yu, 2022, International journal of pharmaceutics.

Cellular uptake, intracellular behavior, and acute/sub-acute cytotoxicity of a PEG-modified quantum dot with promising in-vivo biomedical applications

Y. Duan, Cuiwen Zhu, Dongxu Li, 2023, Heliyon.